NCT03663348 Registry of Patients With Takotsubo Syndrome
| NCT ID | NCT03663348 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Takotsubo Cardiomyopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2009-09-11 |
| Primary Completion | 2028-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2009-09-11 with a primary completion date of 2028-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Takotsubo syndrome is a condition which mimics acute myocardial infarction, and is diagnosed in 1.5% to 2.2% of patients referred to hospital with suspected acute coronary syndrome. It is also known as broken heart syndrome, takotsubo cardiomyopathy, stress cardiomyopathy and apical ballooning cardiomyopathy, among other names. The pathogenesis of this disorder is not well understood. Possible mechanisms include catecholamine excess, coronary artery spasm, microvascular dysfunction, among others. This is a multicenter, nation-wide, observational study of patients who were previously diagnosed with takotsubo syndrome. The investigators aim to use this registry to help plan and carry out further studies and to improve understanding of the pathophysiologic mechanisms of this syndrome. In addition participants will be followed for events, and to monitor quality of life and stress.
Eligibility Criteria
Inclusion Criteria: * Physician diagnosis of takotsubo syndrome * Age\>18 years Exclusion Criteria: \- Lack of capacity to provide informed consent
Contact & Investigator
Harmony Reynolds, MD
✉ brokenheartstudy@nyumc.orgFrequently Asked Questions
Who can join the NCT03663348 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 110 Years, studying Takotsubo Cardiomyopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03663348 currently recruiting?
Yes, NCT03663348 is actively recruiting participants. Contact the research team at brokenheartstudy@nyumc.org for enrollment information.
Where is the NCT03663348 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT03663348 clinical trial?
NCT03663348 is sponsored by NYU Langone Health. The trial plans to enroll 500 participants.